Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The opiate receptor.

× No keyword cloud information.

10 in total

Review 1. Neurochemistry and behavior in man.

Authors: G S Omenn
Journal: West J Med Date: 1976-12

Review 2. Mu opioids and their receptors: evolution of a concept.

Authors: Gavril W Pasternak; Ying-Xian Pan
Journal: Pharmacol Rev Date: 2013-09-27 Impact factor: 25.468

3. Conformation and electrostatic potential surfaces of opiates: Relationship to µ- and λ-site binding.

Authors: T P Lybrand; P A Kollman; V C Yu; W Sadée
Journal: Pharm Res Date: 1986-08 Impact factor: 4.200

4. Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.

Authors: L C Tang; G C Cotzias
Journal: Proc Natl Acad Sci U S A Date: 1978-03 Impact factor: 11.205

5. Prescribing narcotics to habitual and addicted narcotic users. Medical and legal guidelines in California and some other Western states.

Authors: F S Tennant; G F Uelmen
Journal: West J Med Date: 1980-12

6. Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.

Authors: Samuel Obeng; Abdulmajeed Jali; Yi Zheng; Huiqun Wang; Kathryn L Schwienteck; Chongguang Chen; David L Stevens; Hamid I Akbarali; William L Dewey; Mathew L Banks; Lee-Yuan Liu-Chen; Dana E Selley; Yan Zhang
Journal: ACS Chem Neurosci Date: 2019-02-21 Impact factor: 4.418

The opiate receptor.

Review 1. Neurochemistry and behavior in man.

Review 2. Mu opioids and their receptors: evolution of a concept.

3. Conformation and electrostatic potential surfaces of opiates: Relationship to µ- and λ-site binding.

4. Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.

5. Prescribing narcotics to habitual and addicted narcotic users. Medical and legal guidelines in California and some other Western states.

6. Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.

7. Naloxone-reversible analgesic action of SKF 525-A in mice.

8. Influence of naloxone on the total capacitance vasculature of the dog.

9. Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.

Review 10. Clinical features and management of intoxication due to hallucinogenic drugs.